CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Technological advancements in cardiac monitoring & cardiac rhythm management
devices
4.1.2. Rising incidence of cardiovascular diseases
4.1.3. Smart wearable ECG monitors
4.1.4. Increasing Opportunities in the developing countries
4.2. Market Restraints & Challenges
4.2.1. Limited reimbursements for remote cardiac monitoring devices
4.2.2. Price-sensitive market & Frequent product recalls
4.2.3. Lack of skilled professionals with expertise in electrocardiography and cardiac rhythm
management devices
CHAPTER 5. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM
MANAGEMENT DEVICES MARKET – BY PRODUCT
5.1. Electrocardiogram (ECG) Devices
5.1.1. By Type
5.1.1.1. Resting ECG Devices
` 5.1.1.2. Stress ECG Devices
5.1.1.3. ECG Holter Monitors
5.1.1.3.1. Wired Holter Monitors
5.1.1.3.2. Wireless Holter Monitors
5.1.2. By Lead Type
5.1.2.1. Single Lead
5.1.2.2. 3-6 Lead
5.1.2.3. 12-Lead
5.2. Cardiac Output Monitoring (COM) Devices
5.2.1. Minimally Invasive COM Devices
5.2.2. Non-Invasive COM Devices
5.3. Implantable Loop Recorder
5.4. Event Monitors
5.4.1. By Type
5.4.1.1. Pre-Symptom
5.4.1.2. Post-Symptom
5.4.2. By Technology
5.4.2.1. Manual Event Monitors
5.4.2.2. Autodetect Monitors
5.5. Cardiac Resynchronization Therapy (CRT) Devices
5.5.1. CRT-P
5.5.2. CRT-D
5.6. Others
CHAPTER 6. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM
MANAGEMENT DEVICES MARKET – BY END USER
6.1. Home settings
6.2. Hospitals & Clinics
6.3. Others
CHAPTER 7. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM
MANAGEMENT DEVICES MARKET – BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.8. Switzerland
7.4.9. Poland
7.4.10. Others
7.5. APAC
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM
MANAGEMENT DEVICES MARKET - COMPANY PROFILES
8.1. General Electric Company
8.2. Boston Scientific Corporation
8.3. Biotronik Se & Co. Kg
8.4. Berlin Heart Gmbh
8.5. Cardiac Science Corporation
8.6. Abiomed, Inc.
8.7. Medtronic PLC
8.8. Koninklijke Philips N.V.
8.9. Livanova PLC
8.10. Nihon Kohden Corporation
8.11. Schiller Ag
8.12. St. Jude Medical, Inc.
CHAPTER 9. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM
MANAGEMENT DEVICES MARKET – COMPETITIVE LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10. MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11. APPENDIX
11.1. List of Tables
11.2. List of Figures
